VI

Vicapsys Life Sciences, Inc.

VICP·92560A106·US·Common Stock·Healthcare - Biotechnology-13D/G

VICP (Vicapsys Life Sciences, Inc.) is held by 0 institutional investors as of Q3 2022.

0
Holders
Avg rating(1 Elite)
$0
Total Value
0% (1)
Fund Consensus

No verdict yet — fewer than 2 funds hold VICP.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used